Now, we are eager to expand and enhance our
CRISPR technology with pluripotent stem cells in our lab! We spend three days
at the Humboldt-University of Berlin with a bunch of great pioneers of the
CRISPR-Cas field, including Emmanuelle Charpentier (Berlin), Anita Marchfelder
(Ulm), and Malcolm White (UK) – to name only a few fantastic visionaries.
A
keynote lecture held by Emmanuelle Charpentier was a great opportunity for
non-CRISPR scientists to get an overview of the beginning years and the great
success of the CRISPR-Cas gene editing era – unbelievable what has been made
possible in genetic research within such a short time since 2012.
The
combination or bioengineering of different Cas orthologues may push the field
even further towards a versatile, efficient and biologically safe gene therapy
in order to combat rare monogenic or even complex polygenic inheritable diseases.
MM, TS
Comments
Post a Comment